GlaxoSmithKline (GSK) to Close U.K. Research Center - DJN
Tweet
Share
E-mailGet Alerts GSK Hot Sheet
Join SI Premium – FREE
According to a Dow Jones Newswire, GlaxoSmithKline (NYSE: GSK) is to shutter a U.K. research center following the completion of a study on pain relief, anxiety, and depression.
The loss of jobs would amount to about 380.
The loss of jobs would amount to about 380.
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Array shifts to integrated solar platform with record orderbook
- BTIG notes elevated delinquencies in Affirm ABS vintages
Create E-mail Alert Related Categories
General NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
